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LETTERS TO THE EDITOR
Plasma Concentrations of
Bacterial Lipopolysaccharide:
A Marker of Infection or Inflammation?
The article by Wiedermann et al. (1) sheds more light on the
potential importance of elevated plasma concentrations of bacterial
lipopolysaccharide (LPS). This is, however, not the first published
report on elevated LPS concentrations in cardiovascular disease.
We proposed in 1997 that raised LPS plasma concentrations
(potentially as a consequence of intestinal translocation) might be
expected in patients with chronic heart failure (CHF) (2). Re-
cently, we have demonstrated that low grade but significant
endotoxemia is present in edematous patients with CHF, which
was lowered after diuretic treatment (3).
Wiedermann et al. (1) discuss the importance of chronic and
potentially repetitive infection as a cause for atherosclerosis. We
would like to ask the authors which clinical signs of acute or
chronic infection have or have not been documented in their study
group at the time of the initial investigation. Was the measure-
ment of body temperature included in the clinical evaluation
protocol? If there were patients with clinical signs of an ongoing
infection, did they have higher LPS plasma concentrations than
noninfected patients? Did the study’s principal results of the
relation between LPS and atherosclerosis remain the same after
exclusion of these patients? How often was the diagnosis of
infection based on biochemical measurements such as C-reactive
protein (CRP) alone? CRP is an acute-phase protein, and primar-
ily it is a sign of inflammation. Noninfectious processes such as
hypoxia have been shown to cause inflammatory cytokine activa-
tion (4), which in turn can raise CRP levels (5). The presence of
LPS in the bloodstream does not necessarily indicate the presence
of bacteria in the circulation or bacterial infection. An alternative
hypothesis to explain raised LPS levels in some patients in the
study (1) could be that bacterial translocation across the intestinal
wall occurs, potentially due to atherosclerotic processes in the
mesenteric vasculature, contributing to local tissue ischemia.
The report raises another very important point. To date, there is
no consensus on how to measure plasma LPS concentrations. In
contrast to the methodology applied by Wiedermann et al. (1), we
use LPS-free vacuum blood collection tubes (Endot Tube ET,
Chromogenix, Mo¨lndal, Sweden) (3). These tubes have been
developed specifically for the measurement of LPS plasma con-
centrations. After centrifugation, these tubes can be stored directly
in a freezer. This eliminates the aliquoting process at the time of
sampling in the clinic, which is thought to be the main source of
contamination. The processing of the samples can then be per-
formed under sterile laboratory conditions at the time of LPS
analysis. The use of standard tubes for the assessment of LPS
concentrations in blood may need validation.
We agree with Wiedermann et al. (1) and Carlquist (6) that the
pathophysiologic importance of bacterial LPS may potentially be
transferable to a much broader spectrum of clinical conditions
beyond sepsis. Although endotoxin antibodies have failed in septic
patients, they may be of value in patients with cardiovascular
diseases.
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REPLY
Chronic infections have been implicated in the etiology of atheroscle-
rosis, but this presumed association remains controversial (1). Pro-
spective data from the Bruneck study revealed an association between
atherosclerosis and endotoxemia, which was particularly evident in
smokers and patients with recurrent bacterial infections (2).
In an effort to identify patients with chronic infections or
conditions known to be associated with recurrent episodes of
exacerbation of infectious disease, we initiated an extensive screen-
ing process consisting of two consecutive phases (3). The first step
involved obtaining a detailed self-reported medical and medication
history, a thorough clinical examination, spirometric measure-
ments, laboratory tests including acute-phase reactants, serologic
markers of chronic infection and urinary analysis and a review of
Bruneck Hospital’s data bases and medical records provided by
general practitioners and dentists. The situation in Bruneck is
unique in that the majority of subjects are treated in the local
hospital, which offers the only facilities for radiography, computed
tomography, lung function testing and microbiologic tests in the
survey area. If data were inconclusive or incomplete, individuals
were, in a second step, referred for further optional examinations.
The diagnosis of common chronic infections was established
according to standard diagnostic criteria by an expert committee
including medical subspecialists, all of whom had no knowledge of
the results of the ultrasound evaluations. Blood samples were
drawn after an overnight fast and 12 h abstinence from smoking
(4). In patients with an acute infectious disease, samples were
drawn after an interval of at least six weeks from the time of the
outbreak of the disease. Thus, endotoxemia was not measured
during an acute infection or an episode of exacerbation of chronic
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infection. None of the patients in the study had a fever. The
diagnosis of infection was never based on biochemical measure-
ments of C-reactive protein alone.
Commercially available blood collection tubes and heparin used
for anticoagulation may be contaminated with endotoxin (5,6).
Therefore, in our study, the use of standard tubes for the
assessment of endotoxin concentrations in plasma was validated: 1)
Aliquots from the blood sampling tubes were filled with
endotoxin-free cell culture medium and tested for endotoxin after
comparable sample handling. No endotoxin was detected by the
commercial test kit used. 2) To further exclude contamination of
samples by endotoxin, a sensitive bioassay was used to measure in
vitro endothelial cell activation for neutrophil transmigration (7).
Aliquots from blood sampling tubes filled with endotoxin-free cell
culture medium with and without 10 mg/ml of polymyxin B had no
effect on endothelial cell activation for leukocyte transmigration,
thus confirming the lack of endotoxin contamination.
Rauchhaus et al. suggest an alternative hypothesis to explain
endotoxemia in terms of bacterial translocation across the intesti-
nal wall due to atherosclerotic processes in the mesenteric vascu-
lature. However, because the observed association between endo-
toxemia at baseline and carotid atherosclerosis at follow-up was
particularly pronounced in patients who had no coronary artery
disease and in whom there was no ultrasound evidence of carotid
and femoral artery atherosclerosis at baseline, it is unlikely that
intestinal ischemia with bacterial translocation was present in these
patients when endotoxin samples were obtained at baseline.
Furthermore, recent data show that elevated levels of antibodies to
lipopolysaccharide from Escherichia coli, probably reflecting suc-
cessful immune responses to intestinal translocation of bacteria, are
inversely related to carotid artery atherosclerosis and are not
associated with endotoxemia (manuscript submitted). These data
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DNA in Blood Mononuclear Cells
The report by Wong et al. (1), on the detection of Chlamydia
pneumoniae (Cpn) DNA in the peripheral blood mononuclear cells
(PBMCs) of a small proportion (,10%) of patients with coronary
artery disease (CAD), raises several interesting issues. There is a
strong desire to have an easily determined marker of Cpn in the
arterial wall, because obtaining atheromatous tissue is likely to be
a rare event and serologic assessments, as pointed out by Wong et
al. and Kaski and Camm in the accompanying editorial (2), are of
no help. The question is whether the weak association between
Cpn DNA in PBMCs and CAD in men, said to be a predictor of
CAD, is meaningful. The same association was not seen for
women. Reasons for the failure to show the same association in
women are suggested (hormones?), but could it be that the lack of
association for women is the most plausible result? Surely those
without CAD in the age group studied are not devoid of
artheromatous changes in other major vessels; and Cpn DNA has
been detected in a large proportion of all major vessels examined
(3). Thus, if there is a relation between atheromatous lesions and
PBMCs carrying Cpn DNA, the latter finding might be expected
irrespective of the existence of CAD. Thought should be given to
the possibility that the positive association in men, despite statis-
tical significance, is spurious, and that the negative association in
women is not so bewildering. Curious, however, is the finding of
Cpn DNA in the PBMCs of ,10% of patients. Wong et al. (1)
regard the large proportion (.50%) of patients, including blood
donors, with such cells reported by Bowman et al. (4) in Sweden
to be remarkable; the Southampton workers refer to possible
geographic differences to explain these different proportions. We
are inclined to think that this is not plausible in view of some of
our observations in ongoing studies. Thus, in examining PBMCs
from subjects in the United Kingdom with peripheral vascular
disease, we have found 47% of the samples to be Cpn-positive by
polymerase chain reaction. In addition, donors ($15 years old) of
hearts for transplantation whose vessels (principally ascending
aorta and pulmonary artery) were Cpn-positive were less likely to
have spleen cells, presumably containing PBMCs, that were
Cpn-positive than were donors whose vessels were Cpn-negative.
Overall, 37% of the spleen specimens were positive. Therefore, we
think that the relation between Cpn DNA in circulating mono-
cytes and CAD remains enigmatic. Doubtless, the true situation
will become clear eventually. In the meanwhile, to suggest that
Cpn DNA in PBMCs is a predictor of CAD in men, but not in
women—that is, in ,10% of them—and that they stand out as
having an “active” infection and might benefit from antibiotic
therapy, seems misplaced. Fortunately, the antibiotic trials cur-
rently in progress are being undertaken with complete disregard for
the PBMC Cpn DNA status of the patients.
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